Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD

Wang, A., Shulman, M., Choo, T., Pavlicova, M., Langleben, D. D., Nunes, E. V., & Rotrosen, J. (2021). Baseline‐ and treatment‐associated pain in the X:BOT comparative effectiveness study of extended‐release naltrexone versus buprenorphine‐naloxone for OUD. Addiction Biology, 27(2). Portico. https://doi.org/10.1111/adb.13112
Authors:
An-Li Wang
Matisyahu Shulman
Tse-Hwei Choo
Martina Pavlicova
Daniel D. Langleben
Edward V. Nunes
John Rotrosen
Affiliated Authors:
Matisyahu Shulman
Tse-Hwei Choo
Martina Pavlicova
Edward V. Nunes
Subjects:
Author Keywords:
buprenorphine-naloxone
injectable extended-release naltrexone
pain
Publication Type:
Article
Unique ID:
10.1111/adb.13112
PMID:
Publication Date:
Data Source:
Scopus

Record Created: